Results 21 to 30 of about 4,760,123 (57)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
New England Journal of Medicine, 2017 J. Weber, M. Mandalà, M. Del Vecchio, H. Gogas, A. Arance, L. Cowey, S. Dalle, M. Schenker, V. Chiarion-Sileni, I. Márquez-Rodas, J. Grob, M. Butler, M. Middleton, M. Maio, V. Atkinson, P. Queirolo, R. Gonzalez, R. Kudchadkar, M. Smylie, N. Meyer, L. Mortier, M. Atkins, G. Long, S. Bhatia, C. Lebbé, P. Rutkowski, K. Yokota, N. Yamazaki, T. M. Kim, V. de Pril, J. Sabater, A. Qureshi, J. Larkin, P. Ascierto +33 moresemanticscholar +1 more sourceAdjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
New England Journal of Medicine, 2018 A. Eggermont, C. Blank, M. Mandalà, G. Long, V. Atkinson, S. Dalle, A. Haydon, M. Lichinitser, A. Khattak, M. Carlino, S. Sandhu, J. Larkin, S. Puig, P. Ascierto, P. Rutkowski, D. Schadendorf, R. Koornstra, L. Hernandez-Aya, M. Maio, A. V. D. van den Eertwegh, J. Grob, R. Gutzmer, R. Jamal, P. Lorigan, N. Ibrahim, S. Marréaud, A. V. van Akkooi, S. Suciu, C. Robert +28 moresemanticscholar +1 more sourceIncreased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
Hepatology, 2017 P. Dulai, Siddharth Singh, J. Patel, Meera Soni, L. Prokop, Z. Younossi, G. Sebastiani, M. Ekstedt, Hannes Hagstrom, Patrik Nasr, P. Stål, V. Wong, S. Kechagias, R. Hultcrantz, R. Loomba +14 moresemanticscholar +1 more sourceAdjuvant Dabrafenib plus Trametinib in Stage III BRAF‐Mutated Melanoma
New England Journal of Medicine, 2017 G. Long, A. Hauschild, M. Santinami, V. Atkinson, M. Mandalà, V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert, L. Mortier, J. Schachter, D. Schadendorf, T. Lesimple, R. Plummer, R. Ji, Pingkuan Zhang, B. Mookerjee, J. Legos, R. Kefford, R. Dummer, J. Kirkwood +22 moresemanticscholar +1 more sourceDirect detection of early-stage cancers using circulating tumor DNA
Science Translational Medicine, 2017 J. Phallen, M. Sausen, V. Adleff, A. Leal, C. Hruban, J. White, V. Anagnostou, J. Fiksel, S. Cristiano, E. Papp, Savannah Speir, T. Reinert, Mai-Britt Worm Orntoft, Brian D. Woodward, D. Murphy, S. Parpart-Li, David R. Riley, Monica C. Nesselbush, Naomi A. Sengamalay, Andrew P. Georgiadis, Q. K. Li, M. Madsen, F. Mortensen, J. Huiskens, C. Punt, N. V. van Grieken, R. Fijneman, G. Meijer, H. Husain, R. Scharpf, L. Diaz, Siân Jones, Samuel V. Angiuoli, T. Ørntoft, H. Nielsen, C. Andersen, V. Velculescu +36 moresemanticscholar +1 more sourceDuration of Adjuvant Chemotherapy for Stage III Colon Cancer
New England Journal of Medicine, 2018 A. Grothey, A. Sobrero, A. Shields, T. Yoshino, J. Paul, J. Taieb, J. Souglakos, Q. Shi, R. Kerr, R. Labianca, J. Meyerhardt, D. Vernerey, T. Yamanaka, I. Boukovinas, J. Meyers, L. Renfro, D. Niedzwiecki, Toshiaki Watanabe, V. Torri, M. Saunders, D. Sargent, T. André, T. Iveson +22 moresemanticscholar +1 more sourceProlonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
New England Journal of Medicine, 2016 A. Eggermont, V. Chiarion-Sileni, J. Grob, R. Dummer, J. Wolchok, H. Schmidt, O. Hamid, C. Robert, P. Ascierto, J. Richards, C. Lebbé, V. Ferraresi, M. Smylie, J. Weber, M. Maio, L. Bastholt, L. Mortier, L. Thomas, S. Tahir, A. Hauschild, Jessica C Hassel, F. Hodi, C. Taitt, V. de Pril, Gaetan de Schaetzen, S. Suciu, A. Testori +26 moresemanticscholar +1 more source
